Fight Kids Cancer 3 Million Call for proposals

European childhood cancer parents' and patients' representatives' organisations are providing new opportunities to fund innovative treatments to improve survival and quality of life

The Fight Kids Cancer programme is an exciting new venture supported by three European parents' and patients’ representative organisations that have joined forces to launch an exciting opportunity supporting academic research for paediatric cancers.

This first call will offer a total of 3 million euros to support the best clinical and translational research projects that accelerate therapeutic innovation for children and adolescents with cancer. Our founding organisations are:

Call Priorities

The Fight Kids Cancer programme (hereafter “FKC”) aims to catalyse and support pan-
European
innovative and relevant research initiatives in paediatric cancer to develop new therapies that improve the outcome for all children and adolescents with cancer. This call will cover the following three non-exclusive themes:

  1. To produce world-leading science to advance knowledge of paediatric malignancies.
  2. To support improved interdisciplinary knowledge, methods and collaborations for the issues of today.
  3. To strengthen collaboration and the development of scientific capacity across Europe.

This call will prioritise areas that effectively benefit the young patients by:

  • improving their survival rate
  • improving their quality of life during and after the treatments
  • improving our knowledge on cancer causes and treatment resistance

The aims for FKC call for projects include overcoming the structural lack of research dedicated to paediatric cancers by ensuring a recurring endowment that will be granted to the best European research projects every year.

Eligibility

Funding will support new research projects across Europe. The lead institution must be from the list of eligible countries, with preference given to institutions with a strong track record paediatric cancer research. Other project partners are encouraged and can be from related fields of expertise, providing they operate as not-for-profit. See Guidance for Applicants for details.

Eligible countries included are: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom.

Funding

For this call, we intend to fund up to two early phase clinical trials (max EUR 1.5M per project) and up to three translational research projects (max EUR 500K per project).

Call Schedule

A two-step announcement process will apply, with a pre-announcement in December 2019 and submission of full proposals will open mid-January 2020, to be submitted via an Electronic Proposal Submission System.

-    Pre-announcement of the call: 02 December 2019
-    Call launched and online submission portal open: Mid-January 2020
-    Deadline for full-proposals submission:1 April 2020, 16:00 CET (UTC+1)

Call Documents

Please see the Guidance for Applicants document below for full details of the call.

-  Consult the complete guidance documents (including the scientific call text, further information on procedures, evaluation criteria, etc.).

-  Consult the full proposal application form (.doc version) - for information only, submission of full proposals needs to be completed online, via the electronic portal.

Programme Management

Programme support and management is provided by the European Science Foundation, which acts as the secretariat office for the funding organisations.  

For further information about this announcement of opportunity please contact:

FKC secretariat at ESF:  fightkidscancer[at]esf[dot]org